Neurol. praxi. 2017;18(2):103-108 | DOI: 10.36290/neu.2017.050

Smoking and multiple sclerosis

doc. MUDr. Radomír Taláb, CSc.1, MUDr. Marika Talábová2
1Neurologická klinika LF UK a FN Plzeň, 2Neurologická klinika LF UK a FN Hradec Králové

Multiple sclerosis (MS) is a chronic inflammatory disease wherein demyelination and axonal loss occur in the central nervous system

(CNS). MS is a multifactorial disease in which environmental factors can be responsible for triggering an autoimmune response

in genetically susceptible individuals. Environmental factors typically act in combination, while being less selective and having

an effect on the pathogenesis of MS. A complex interplay between individual genetic predisposition and environmental factors

in MS affects both the incidence of MS and its clinical form. The most significant factors include smoking, reduced vitamin D

concentration, reduced UV light exposure, high sodium chloride level, and early Epstein-Barr virus (EBV) infection.

Keywords: multiple sclerosis, smoking, environmental risk factors

Received: October 19, 2017; Accepted: November 12, 2017; Published: May 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Taláb R, Talábová M. Smoking and multiple sclerosis. Neurol. praxi. 2017;18(2):103-108. doi: 10.36290/neu.2017.050.
Download citation

References

  1. Anstey KJ, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007; 166: 367-378. Go to original source... Go to PubMed...
  2. Antonowsky A, Leibowitz U, Smith HA, Medalie JM, Balongh M, Kats R. Epidemiologic study of multiple sclerosis in Israel. An overal review of methods and findings. Arch neurol 1965, 13: 183-193. Go to original source... Go to PubMed...
  3. Carlens C, Hergens MP, Grunewald J, Ekbom A, Eklund A, Hoglund CO. Smoking, use of moist snuff, and risk of chronic inflamatory disease. Am J Respir Crit Care Med 2010; 181: 1217-1222. Go to original source... Go to PubMed...
  4. Gandey A. Smoking boots multiple sclerosis risk. Neurology, 2009; 73: 696-701. Go to original source... Go to PubMed...
  5. Ghadirian P, Dadgostar B, Azani R, Maisonneuve P. A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis. Can J Public Health 2001; 92: 281-285. Go to original source... Go to PubMed...
  6. Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L. Exposure to enviromental tabacco smoke is associated with increased risk for multiple sclerosis, Mult Scler 2011; 17(7): 788-793. Go to original source... Go to PubMed...
  7. Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L. Tabacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009; 73: 696-701. Go to original source... Go to PubMed...
  8. Hedström AK, Hillert J, Olsson T, Alfredsson L. Nicotine might have e protective effect in the etiology of multiple sclerosis. Mult Scler 2013; 19(8): 1009-1013. Go to original source... Go to PubMed...
  9. Hedström AK, Sundquist E, Bäämhielm M, Nordin N, Hilert J, Kockum I, Olsson T, Andersson L. Smoking and two human leukocyte antigen genes Interact to increase the risk for multiple sclerosis. Brain 2011; 134(3): 653-664. Go to original source... Go to PubMed...
  10. Jeffrey S. Smoking linked to increased mortality in MS. 28. Congres of ECTRIMS 2012; Abstract 65, P375.
  11. Mandia D, Ferraro OE, Nosari G, Montomoli C, Zardini E, Bergamaschi R. Environmental factors and multiple sclerosis severity: a Descripite study. Int J Environ Res Public Health 2014; 11: 6417-6432. Go to original source... Go to PubMed...
  12. Manouchehrinia A, Weston M, Tench CR, Britton J, Constantinescu CS. Tabacco smoking and excess mortality in multiple sclerosis: a cohort study. J neurol neurosurg Psychiatry 2014; 85(10): 1091-1095. Go to original source... Go to PubMed...
  13. Ozcan ME, Ince B, Bingol A, Erturk S, Altmoz MA, Karadeli HH, Kocer A, Asil T. Association between smoking and cognitive impairment in multiple sclerosis. Neuropsychiatric Disease and Treatment 2014; 10: 1715-1719. Go to original source... Go to PubMed...
  14. Ramanujam R, Hedström AK, Manouchehrinia A, Alfredsson L, Olsson T, Bottai M, Hiller J. Effect of smoking cessation on multiple sclerosis prognosis. JAMA Neurol 2015; 72(10): 1117-1123. Go to original source... Go to PubMed...
  15. Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, Ebers GC. The Natural history of multiple sclerosis: a geographical based study 10: relapses and disability. Brain 2010; 133(Pt 7): 1914-1929. Go to original source... Go to PubMed...
  16. The economics of tobacco and tobacco control. National cancer institute tobacco control monograph 21. NIH Publication No. 16-CA-8029A. Bethesda, MD: U.S. Department of health and human services, National institutes of health, National cancer institute; and Geneva, CH: World Health Organization; 2016. http://cancercontrol.cancer.gov/brp/tcrb/monographs/21/index.html.
  17. Weston M, Constantinescu CS. What role does tabacco smoking play in multiple sclerosis disability and mortality? A review of the evidence Neurogener. Dis. Manag. 2015; 5(1): 19-25. Go to original source...
  18. Wingerchuk DM. Smoking: Effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disorders 2012; 5(1): 13-22. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.